Cargando…
Chemo-Immunotherapy Using Lentinan for the Treatment of Gastric Cancer with Liver Metastases
Gastric cancer is the third leading cause of cancer-related mortality worldwide. Systemic chemotherapy is the main treatment option for advanced gastric cancer when the tumor is inoperable. Despite recent advances in chemotherapeutic agents, the prognosis of unresectable or recurrent gastric cancer...
Autores principales: | Ina, Kenji, Furuta, Ryuichi, Kataoka, Takae, Kayukawa, Satoshi, Ina, Hiroko, Yoneda, Masahiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5635777/ https://www.ncbi.nlm.nih.gov/pubmed/29083372 http://dx.doi.org/10.3390/medsci4020008 |
Ejemplares similares
-
The Use of Lentinan for Treating Gastric Cancer
por: Ina, Kenji, et al.
Publicado: (2013) -
Bladder squamous cell cancer accompanied by Trousseau's syndrome: a case report
por: Kayukawa, Satoshi, et al.
Publicado: (2018) -
Serological response 5 months after the BNT162b2 COVID-19 vaccination in patients with various hematological disorders in Japan
por: Marumo, Yoshiaki, et al.
Publicado: (2023) -
Diagnosis of a
SMARCA4
‐deficient undifferentiated tumor using multigene panel testing: A case report
por: Marumo, Yoshiaki, et al.
Publicado: (2023) -
Complete response of metastatic gastric cancer to chemoimmunotherapy
por: Ina, Kenji, et al.
Publicado: (2017)